“As a service provider in the pharmaceutical industry, we want to be where there’s innovation,” Ralf Sibbing said in describing the objective of the new Diapharm branch office in Shanghai. He added, “More than three quarters of all active ingredients for European medicines are produced outside of Europe. The majority of those ingredients are being manufactured in China.” After decades of European manufacturers opening branch offices in Asia, many Chinese manufacturers are now looking to expand to the West: “We want to advise and assist these manufacturers as they make their way to Europe,” Sibbing said. Among other things, Diapharm helps manufacturers to get drugs approved and assist them with achieving quality assurance in accordance with European standards.